Rhee Ki-Jong, Lee Jong In, Eom Young Woo
Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, 1 Yonseidae-gil, Wonju 26493, Korea.
Department of Hematology-Oncology, Wonju College of Medicine, Yonsei University, 20 Ilsan-ro, Wonju 26426, Korea.
Int J Mol Sci. 2015 Dec 16;16(12):30015-33. doi: 10.3390/ijms161226215.
Mesenchymal stem cells (MSCs) can exhibit a marked tropism towards site of tumors. Many studies have reported that tumor progression and metastasis increase by MSCs. In contrast, other studies have shown that MSCs suppress growth of tumors. MSCs contribute to tumor growth promotion by several mechanisms: (1) transition to tumor-associated fibroblasts; (2) suppression of immune response; (3) promotion of angiogenesis; (4) stimulation of epithelial-mesenchymal transition (EMT); (5) contribution to the tumor microenvironment; (6) inhibition of tumor cell apoptosis; and (7) promotion of tumor metastasis. In contrast to the tumor-promoting properties, MSCs inhibit tumor growth by increasing inflammatory infiltration, inhibiting angiogenesis, suppressing Wnt signaling and AKT signaling, and inducing cell cycle arrest and apoptosis. In this review, we will discuss potential mechanisms by which MSC mediates tumor support or suppression and then the possible tumor-specific therapeutic strategies using MSCs as delivery vehicles, based on their homing potential to tumors.
间充质干细胞(MSCs)可表现出对肿瘤部位的显著趋向性。许多研究报道,MSCs会促进肿瘤进展和转移。相比之下,其他研究表明MSCs可抑制肿瘤生长。MSCs通过多种机制促进肿瘤生长:(1)转变为肿瘤相关成纤维细胞;(2)抑制免疫反应;(3)促进血管生成;(4)刺激上皮-间质转化(EMT);(5)对肿瘤微环境的作用;(6)抑制肿瘤细胞凋亡;以及(7)促进肿瘤转移。与促肿瘤特性相反,MSCs通过增加炎症浸润、抑制血管生成、抑制Wnt信号和AKT信号以及诱导细胞周期停滞和凋亡来抑制肿瘤生长。在本综述中,我们将讨论MSCs介导肿瘤支持或抑制作用的潜在机制,然后基于其对肿瘤的归巢潜力,探讨以MSCs作为递送载体的可能的肿瘤特异性治疗策略。